K152501 is an FDA 510(k) clearance for the Spinal Jaxx Interbody Fusion Device. Classified as Intervertebral Fusion Device With Bone Graft, Lumbar within the MAX classification (a category for intervertebral fusion devices and spinal implants), Class II - Special Controls.
Submitted by Neuropro Spinaljaxx, Inc. (Modesto, US). The FDA issued a Cleared decision on June 29, 2016 after a review of 302 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.
View all Neuropro Spinaljaxx, Inc. devices